|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 3101 to 3200 out of 6467 for Myc

0.03s

Categories

Hits by Pathway

Hits by Category

Hits by Strain

Type Details Score
Allele
Name: collagen, type I, alpha 1; targeted mutation 1, Virginia Smith Shapiro
Allele Type: Targeted
Attribute String: Epitope tag, Inserted expressed sequence
Allele
Name: gene trap ROSA 26, Philippe Soriano; targeted mutation 1, Karolinska Institutet
Allele Type: Targeted
Attribute String: Conditional ready, Inserted expressed sequence, Reporter
Allele
Name: bone morphogenetic protein 4; targeted mutation 3, Jan L Christian
Allele Type: Targeted
Attribute String: Epitope tag
Allele
Name: myelocytomatosis oncogene; endonuclease-mediated mutation 2, Shanghai Model Organisms Center
Allele Type: Endonuclease-mediated
Attribute String: Conditional ready, No functional change
Allele
Name: myelocytomatosis oncogene; targeted mutation 1, Shanghai Model Organisms Center
Allele Type: Targeted
Attribute String: Conditional ready, No functional change
Allele
Name: sortilin-related receptor, LDLR class A repeats-containing; endonuclease-mediated mutation 1, Shanghai Model Organisms Center
Allele Type: Endonuclease-mediated
Attribute String: Conditional ready, No functional change
Strain
Attribute String: coisogenic, mutant strain, transgenic
Strain
Attribute String: mutant strain, congenic, targeted mutation
Allele
Name: gene trap ROSA 26, Philippe Soriano; targeted mutation 3, Gerard Evan
Allele Type: Targeted
Attribute String: Conditional ready, Inducible, Inserted expressed sequence, Reporter
Allele
Name: collagen, type I, alpha 1; targeted mutation 5.1, Yasuhiro Yamada
Allele Type: Targeted
Attribute String: Inducible, Inserted expressed sequence, Reporter
Allele
Name: transgene insertion 34, Jeffrey Robbins
Allele Type: Transgenic
Attribute String: Constitutively active, Epitope tag, Inserted expressed sequence
Genotype
Symbol: Hprt1/?
Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6J
Zygosity: ot
Has Mutant Allele: true
Genotype
Symbol: Hprt1/Hprt1
Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6J
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: Hprt1/?
Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6J
Zygosity: ot
Has Mutant Allele: true
Genotype
Symbol: Hprt1/Hprt1
Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6J
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: Axin1/Axin1
Background: involves: 129S6/SvEvTac * FVB/N
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: Rp1/Rp1
Background: involves: 129S6/SvEvTac
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: Rp1/Rp1<+>
Background: involves: 129S6/SvEvTac * C57BL/6
Zygosity: ht
Has Mutant Allele: true
Genotype
Symbol: Rp1/Rp1
Background: involves: 129S6/SvEvTac * C57BL/6
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: Del(15Rr357-Rr303293)2Jta/Del(15Rr357-Rr303293)2Jta
Background: involves: C57BL/6
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: Tg(IghMyc)186Brn/? Rpl38/Rpl38<+>
Background: involves: C57BL/LiA * CBA/BrA
Zygosity: cx
Has Mutant Allele: true
Genotype
Symbol: Trim63/Trim63
Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: Pkd1/Pkd1
Background: involves: 129S2/SvPas * C57BL/6 * C57BL/6NTac
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: Del(15Rr21-Rr303293)1Jta/Del(15Rr21-Rr303293)1Jta
Background: involves: C57BL/6
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: Tg(Ela1-Myc)159Bri/?
Background: involves: C57BL/6 * SJL
Zygosity: ot
Has Mutant Allele: true
Genotype
Symbol: Pknox1/Pknox1<+> Tg(IghMyc)22Bri/?
Background: involves: C57BL * SJL
Zygosity: cx
Has Mutant Allele: true
Genotype
Symbol: Tg(H2-K-IL6)2Srj/?
Background: B6.Cg-Tg(H2-K-IL6)2Srj
Zygosity: ot
Has Mutant Allele: true
Genotype
Symbol: Dnaaf6rt/Dnaaf6rt
Background: involves: ICR
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: Rr38/Rr38<+>
Background: involves: 129S4/SvJaeSor * BALB/cJ * C57BL/6
Zygosity: ht
Has Mutant Allele: true
Genotype
Symbol: Rr38/Rr38
Background: involves: 129S4/SvJaeSor * BALB/cJ * C57BL/6
Zygosity: hm
Has Mutant Allele: true
Genotype
Symbol: Dnaaf6rt/Dnaaf6rt<+>
Background: involves: ICR
Zygosity: ht
Has Mutant Allele: true
Genotype
Symbol: Gt(ROSA)26Sor/Gt(ROSA)26Sor<+>
Background: involves: C57BL/6
Zygosity: ht
Has Mutant Allele: true
Publication
First Author: Rounbehler RJ
Year: 2012
Journal: Cell
Title: Tristetraprolin impairs myc-induced lymphoma and abolishes the malignant state.
Volume: 150
Issue: 3
Pages: 563-74
Publication
First Author: Ontiveros EP
Year: 2014
Journal: Leuk Lymphoma
Title: A new model of LMP1-MYC interaction in B cell lymphoma.
Volume: 55
Issue: 12
Pages: 2917-23
Publication
First Author: Filipponi D
Year: 2019
Journal: Mol Cell
Title: DNA Damage Signaling-Induced Cancer Cell Reprogramming as a Driver of Tumor Relapse.
Volume: 74
Issue: 4
Pages: 651-663.e8
Publication
First Author: Muthalagu N
Year: 2014
Journal: Cell Rep
Title: BIM is the primary mediator of MYC-induced apoptosis in multiple solid tissues.
Volume: 8
Issue: 5
Pages: 1347-53
Publication
First Author: Previtali SC
Year: 2000
Journal: J Cell Biol
Title: Epitope-tagged P(0) glycoprotein causes Charcot-Marie-Tooth-like neuropathy in transgenic mice.
Volume: 151
Issue: 5
Pages: 1035-46
Publication
First Author: Ellwood-Yen K
Year: 2003
Journal: Cancer Cell
Title: Myc-driven murine prostate cancer shares molecular features with human prostate tumors.
Volume: 4
Issue: 3
Pages: 223-38
Publication
First Author: Chondronasiou D
Year: 2022
Journal: Stem Cell Reports
Title: Deciphering the roadmap of in vivo reprogramming toward pluripotency.
Volume: 17
Issue: 11
Pages: 2501-2517
Publication
First Author: Qi CF
Year: 2007
Journal: Cancer Res
Title: Anaplastic, plasmablastic, and plasmacytic plasmacytomas of mice: relationships to human plasma cell neoplasms and late-stage differentiation of normal B cells.
Volume: 67
Issue: 6
Pages: 2439-47
Publication
First Author: Mérino D
Year: 2012
Journal: Oncogene
Title: Bim must be able to engage all pro-survival Bcl-2 family members for efficient tumor suppression.
Volume: 31
Issue: 28
Pages: 3392-6
Publication
First Author: Bieging KT
Year: 2011
Journal: Blood
Title: A shared gene expression signature in mouse models of EBV-associated and non-EBV-associated Burkitt lymphoma.
Volume: 118
Issue: 26
Pages: 6849-59
Publication
First Author: Hope C
Year: 2014
Journal: Blood
Title: TPL2 kinase regulates the inflammatory milieu of the myeloma niche.
Volume: 123
Issue: 21
Pages: 3305-15
Publication
First Author: Osborne LC
Year: 2010
Journal: Oncogene
Title: Selective ablation of the YxxM motif of IL-7Ralpha suppresses lymphomagenesis but maintains lymphocyte development.
Volume: 29
Issue: 26
Pages: 3854-64
Publication
First Author: Lewis R
Year: 2021
Journal: Leukemia
Title: CXCR4 hyperactivation cooperates with TCL1 in CLL development and aggressiveness.
Volume: 35
Issue: 10
Pages: 2895-2905
Publication
First Author: Vaillant F
Year: 1999
Journal: Oncogene
Title: A full-length Cbfa1 gene product perturbs T-cell development and promotes lymphomagenesis in synergy with myc.
Volume: 18
Issue: 50
Pages: 7124-34
Publication
First Author: Park SS
Year: 2005
Journal: Cancer Res
Title: Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice.
Volume: 65
Issue: 4
Pages: 1306-15
Publication
First Author: Nopparat J
Year: 2015
Journal: Oncogene
Title: δ-Catenin, a Wnt/β-catenin modulator, reveals inducible mutagenesis promoting cancer cell survival adaptation and metabolic reprogramming.
Volume: 34
Issue: 12
Pages: 1542-52
Publication
First Author: Bultema R
Year: 2009
Journal: Oncogene
Title: Epstein-Barr virus LMP2A accelerates MYC-induced lymphomagenesis.
Volume: 28
Issue: 11
Pages: 1471-6
Publication
First Author: Saad F
Year: 2015
Journal: Oncotarget
Title: The IgH 3' regulatory region influences lymphomagenesis in Igλ-Myc mice.
Volume: 6
Issue: 24
Pages: 20302-11
Publication
First Author: Mehta HH
Year: 2011
Journal: Cancer Res
Title: IGFBP-3 is a metastasis suppression gene in prostate cancer.
Volume: 71
Issue: 15
Pages: 5154-63
HT Experiment  
Experiment Type: RNA-Seq
Study Type: WT vs. Mutant
Source: GEO
HT Experiment  
Experiment Type: RNA-Seq
Study Type: WT vs. Mutant
Source: GEO
HT Experiment  
Experiment Type: RNA-Seq
Study Type: Baseline
Source: GEO
HT Experiment  
Experiment Type: RNA-Seq
Study Type: WT vs. Mutant
Source: GEO
HT Experiment  
Experiment Type: RNA-Seq
Study Type: WT vs. Mutant
Source: GEO
Publication
First Author: Asker CE
Year: 1995
Journal: Oncogene
Title: Mouse and rat B-myc share amino acid sequence homology with the c-myc transcriptional activator domain and contain a B-myc specific carboxy terminal region.
Volume: 11
Issue: 10
Pages: 1963-9
Publication
First Author: Sargent LM
Year: 1999
Journal: Am J Pathol
Title: Nonrandom cytogenetic alterations in hepatocellular carcinoma from transgenic mice overexpressing c-Myc and transforming growth factor-alpha in the liver.
Volume: 154
Issue: 4
Pages: 1047-55
Protein
Organism: Mus musculus/domesticus
Length: 77  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 104  
Fragment?: true
Protein
Organism: Mus musculus/domesticus
Length: 72  
Fragment?: true
Protein Domain
Type: Domain
Description: The class III basic helix-turn-helix (bHLH) transcription factors have proliferative and apoptotic roles and are characterised by the presence of a leucine zipper adjacent to the bHLH domain. The myc oncogene gene was first discovered in small-cell lung cancer cell lines where it is found to be deregulated []. Although the biochemical function of the gene product is unknown, as a nuclear protein with a short half-life it may play a direct or indirect role in controlling gene expression []. Myc forms a heterodimer with Max, and this complex regulates cell growth through direct activation of genes involved in cell replication [].This entry represents the N-terminal domain found adjacent to the basic helix-loop-helix (bHLH) region ().
Protein
Organism: Mus musculus/domesticus
Length: 382  
Fragment?: false
Publication
First Author: Reimann M
Year: 2010
Journal: Cancer Cell
Title: Tumor stroma-derived TGF-beta limits myc-driven lymphomagenesis via Suv39h1-dependent senescence.
Volume: 17
Issue: 3
Pages: 262-72
Publication
First Author: Bannasch D
Year: 2001
Journal: Oncogene
Title: Functional interaction of Yaf2 with the central region of MycN.
Volume: 20
Issue: 41
Pages: 5913-9
Publication
First Author: Schreiber-Agus N
Year: 1995
Journal: Cell
Title: An amino-terminal domain of Mxi1 mediates anti-Myc oncogenic activity and interacts with a homolog of the yeast transcriptional repressor SIN3.
Volume: 80
Issue: 5
Pages: 777-86
Publication
First Author: Freie BW
Year: 2008
Journal: Cancer Cell
Title: Ratcheting Myc.
Volume: 14
Issue: 6
Pages: 425-6
Publication
First Author: Kim JS
Year: 2006
Journal: J Pathol
Title: Plasma cell tumour progression in iMycEmu gene-insertion mice.
Volume: 209
Issue: 1
Pages: 44-55
Publication
First Author: Ikeda M
Year: 2022
Journal: Blood Adv
Title: Latent membrane proteins from EBV differentially target cellular pathways to accelerate MYC-induced lymphomagenesis.
Volume: 6
Issue: 14
Pages: 4283-4296
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Publication
First Author: Keil JM
Year: 2020
Journal: Nat Commun
Title: Symmetric neural progenitor divisions require chromatin-mediated homologous recombination DNA repair by Ino80.
Volume: 11
Issue: 1
Pages: 3839
Publication
First Author: Shi L
Year: 2019
Journal: Nat Commun
Title: Robust elimination of genome-damaged cells safeguards against brain somatic aneuploidy following Knl1 deletion.
Volume: 10
Issue: 1
Pages: 2588
Publication  
First Author: Matúš D
Year: 2024
Journal: J Neurosci
Title: Essential Role of Latrophilin-1 Adhesion GPCR Nanoclusters in Inhibitory Synapses.
Volume: 44
Issue: 23
Publication
First Author: Hirano M
Year: 2022
Journal: Nat Metab
Title: MYCL-mediated reprogramming expands pancreatic insulin-producing cells.
Volume: 4
Issue: 2
Pages: 254-268
Publication
First Author: Hömberg N
Year: 2014
Journal: Int J Cancer
Title: CD40-independent natural killer-cell help promotes dendritic cell vaccine-induced T-cell immunity against endogenous B-cell lymphoma.
Volume: 135
Issue: 12
Pages: 2825-33
Publication
First Author: Berns A
Year: 1999
Journal: Cancer Res
Title: Identification and characterization of collaborating oncogenes in compound mutant mice.
Volume: 59
Issue: 7 Suppl
Pages: 1773s-1777s
Publication
First Author: Lee JS
Year: 2004
Journal: Nat Genet
Title: Application of comparative functional genomics to identify best-fit mouse models to study human cancer.
Volume: 36
Issue: 12
Pages: 1306-11
Publication
First Author: Pighi C
Year: 2021
Journal: Blood Adv
Title: Frequent mutations of FBXO11 highlight BCL6 as a therapeutic target in Burkitt lymphoma.
Volume: 5
Issue: 23
Pages: 5239-5257
Publication
First Author: Young RM
Year: 2009
Journal: Blood
Title: Mouse models of non-Hodgkin lymphoma reveal Syk as an important therapeutic target.
Volume: 113
Issue: 11
Pages: 2508-16
Publication
First Author: Fernandez MR
Year: 2022
Journal: Cancer Res
Title: Disrupting the MYC-TFEB Circuit Impairs Amino Acid Homeostasis and Provokes Metabolic Anergy.
Volume: 82
Issue: 7
Pages: 1234-1250
Publication  
First Author: Melendez E
Year: 2022
Journal: Development
Title: Natural killer cells act as an extrinsic barrier for in vivo reprogramming.
Volume: 149
Issue: 8
Publication
First Author: Rutishauser D
Year: 2009
Journal: PLoS One
Title: The comprehensive native interactome of a fully functional tagged prion protein.
Volume: 4
Issue: 2
Pages: e4446
Publication
First Author: Hollern DP
Year: 2014
Journal: Breast Cancer Res
Title: A genomic analysis of mouse models of breast cancer reveals molecular features of mouse models and relationships to human breast cancer.
Volume: 16
Issue: 3
Pages: R59
Publication
First Author: Nilsson LM
Year: 2012
Journal: PLoS Genet
Title: Mouse genetics suggests cell-context dependency for Myc-regulated metabolic enzymes during tumorigenesis.
Volume: 8
Issue: 3
Pages: e1002573
Publication
First Author: Fratta P
Year: 2011
Journal: Hum Mol Genet
Title: P0S63del impedes the arrival of wild-type P0 glycoprotein to myelin in CMT1B mice.
Volume: 20
Issue: 11
Pages: 2081-90
Publication
First Author: Welsh SJ
Year: 2024
Journal: Blood Cancer Discov
Title: Transcriptional Heterogeneity Overcomes Super-Enhancer Disrupting Drug Combinations in Multiple Myeloma.
Volume: 5
Issue: 1
Pages: 34-55
Publication
First Author: Alland L
Year: 1997
Journal: Nature
Title: Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression.
Volume: 387
Issue: 6628
Pages: 49-55
Publication
First Author: Meyer N
Year: 2008
Journal: Nat Rev Cancer
Title: Reflecting on 25 years with MYC.
Volume: 8
Issue: 12
Pages: 976-90
Publication
First Author: Schnepp RW
Year: 2013
Journal: Cancer Discov
Title: Targeting MYCN: a good BET for improving neuroblastoma therapy?
Volume: 3
Issue: 3
Pages: 255-7
Publication
First Author: Altman BJ
Year: 2012
Journal: FEBS J
Title: Normal and cancer cell metabolism: lymphocytes and lymphoma.
Volume: 279
Issue: 15
Pages: 2598-609
Publication  
First Author: Case AJ
Year: 2014
Journal: Redox Biol
Title: Absence of manganese superoxide dismutase delays p53-induced tumor formation.
Volume: 2
Pages: 220-3
Publication
First Author: Zhu Y
Year: 2024
Journal: Circulation
Title: Asparagine Synthetase Marks a Distinct Dependency Threshold for Cardiomyocyte Dedifferentiation.
Volume: 149
Issue: 23
Pages: 1833-1851
Allele  
Name: formin 1; limb deformity TgHD
Allele Type: Transgenic
Publication
First Author: Magdaleno S
Year: 2002
Journal: Neuron
Title: Rescue of ataxia and preplate splitting by ectopic expression of Reelin in reeler mice.
Volume: 33
Issue: 4
Pages: 573-86
Publication
First Author: Schmitt CA
Year: 2002
Journal: Cancer Cell
Title: Dissecting p53 tumor suppressor functions in vivo.
Volume: 1
Issue: 3
Pages: 289-98
Publication
First Author: Ferrao PT
Year: 2012
Journal: Oncogene
Title: Efficacy of CHK inhibitors as single agents in MYC-driven lymphoma cells.
Volume: 31
Issue: 13
Pages: 1661-72
Publication
First Author: Kratzat S
Year: 2012
Journal: PLoS One
Title: Cks1 is required for tumor cell proliferation but not sufficient to induce hematopoietic malignancies.
Volume: 7
Issue: 5
Pages: e37433
Publication
First Author: Nilsson LM
Year: 2007
Journal: Oncogene
Title: Ink4c is dispensable for tumor suppression in Myc-induced B-cell lymphomagenesis.
Volume: 26
Issue: 20
Pages: 2833-9
Publication
First Author: Herold MJ
Year: 2013
Journal: EMBO Rep
Title: Foxo-mediated Bim transcription is dispensable for the apoptosis of hematopoietic cells that is mediated by this BH3-only protein.
Volume: 14
Issue: 11
Pages: 992-8
Publication
First Author: Masuda T
Year: 2014
Journal: J Neurosci
Title: The transcription factor GTF2IRD1 regulates the topology and function of photoreceptors by modulating photoreceptor gene expression across the retina.
Volume: 34
Issue: 46
Pages: 15356-68